SCHEMBL8064824

SCHEMBL8064824

Oc1ccc(C2SCCCS2)cc1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.58
QDPR P09417 3/20 0.43
PTPN1 P18031 1/20 0.43
ALOX5 P09917 1/20 0.43
GAA P10253 3/20 0.40
POLB P06746 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPK1 P28482 3/20 0.37
CYP3A4 P08684 2/20 0.37
ALOX15 P16050 2/20 0.37
HSD17B10 Q99714 2/20 0.37
NFKB1 P19838 1/20 0.37
THPO P40225 1/20 0.37
YWHAG P61981 1/20 0.37
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 2/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29138483 0.79 TSHR (0.70) TSHRMEN1KMT2AMAPK1CYP3A4
SCHEMBL30669503 0.79 TSHR (0.70) TSHRMEN1KMT2AMAPK1CYP3A4
SCHEMBL13414991 0.79 TSHR (0.91) TSHRQDPRPTPN1ALOX5GAA
SCHEMBL7632848 0.78 TSHR (0.44) TSHRGAAPOLBKMT2AMAPK1
SCHEMBL327401 0.77 ALDH1A1 (0.52) TSHRGAAPOLBMEN1KMT2A
SCHEMBL21280037 0.74 TSHR (0.45) TSHRMEN1KMT2ACYP3A4HSD17B10
SCHEMBL9270618 0.72 TSHR (0.46) TSHRGAAPOLBMEN1KMT2A
SCHEMBL9270773 0.71 KDM4E (0.49) TSHRCYP3A4KDM4E
SCHEMBL16597325 0.71 TSHR (0.85) TSHRQDPRPTPN1ALOX5GAA
SCHEMBL9266484 0.69 MAPT (0.50) TSHRALOX5POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11117987-B2 Hydroxyaryl functionalized polymers BRIDGESTONE CORPORATION (JP) 2021-09-14 US disclosed
US-11028195-B2 Hydroxyaryl functionalized polymers BRIDGESTONE CORPORATION (JP) 2021-06-08 US disclosed
US-20190322777-A1 Hydroxyaryl Functionalized Polymers BRIDGESTONE CORPORATION (JP) 2019-10-24 US disclosed
US-20190233557-A1 Hydroxyaryl Functionalized Polymers BRIDGESTONE CORPORATION (JP) 2019-08-01 US disclosed
US-10227425-B2 Hydroxyaryl functionalized polymers BRIDGESTONE CORPORATION (JP) 2019-03-12 US disclosed
US-20150141582-A1 Hydroxyaryl Functionalized Polymers BRIDGESTONE CORPORATION (JP) 2015-05-21 US disclosed
US-20150141582-A1 Hydroxyaryl Functionalized Polymers BRIDGESTONE CORPORATION (JP) 2015-05-21 US disclosed
US-8871871-B2 Hydroxyaryl functionalized polymers BRIDGESTONE CORPORATION (JP) 2014-10-28 US disclosed
US-8871871-B2 Hydroxyaryl functionalized polymers BRIDGESTONE CORPORATION (JP) 2014-10-28 US disclosed
US-7842830-B2 Transition-metal charge-transport materials, methods of fabrication thereof, and methods of use thereof GEORGIA TECH RESEARCH CORPORATION (US) 2010-11-30 US disclosed
US-20100286348-A1 HYDROXYARYL FUNCTIONALIZED POLYMERS BRIDGESTONE CORPORATION (JP) 2010-11-11 US disclosed
US-20100286348-A1 HYDROXYARYL FUNCTIONALIZED POLYMERS BRIDGESTONE CORPORATION (JP) 2010-11-11 US disclosed
US-20080121870-A1 Transition-Metal Charge Transport Materials, Methods Of Fabrication Thereof, And Methods Of Use Thereof GEORGIA TECH RESEACH CORPORATION 2008-05-29 US disclosed
EP-1004623-A1 Aryl thioacetals useful as stabilizers in polymeric materials GREAT LAKES CHEMICAL CORPORATION (US) 2000-05-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190322777-A1 Hydroxyaryl Functionalized Polymers HAAO, HCAR3, VCL TSHR 3633/4885QDPR 2692/4885PTPN1 1077/4885
US-11028195-B2 Hydroxyaryl functionalized polymers HAAO, HCAR3, VCL TSHR 3597/4885QDPR 2846/4885PTPN1 1207/4885
US-10227425-B2 Hydroxyaryl functionalized polymers HAAO, HCAR3, VCL TSHR 3633/4885QDPR 2692/4885PTPN1 1077/4885
US-20150141582-A1 Hydroxyaryl Functionalized Polymers HAAO, HCAR3, VCL TSHR 3633/4885QDPR 2692/4885PTPN1 1077/4885
US-20080121870-A1 Transition-Metal Charge Transport Materials, Methods Of Fabrication Thereof, And Methods Of Use Thereof SLC39A3, SLC6A6, SLC6A9 TSHR 4527/4885QDPR 4284/4885PTPN1 4475/4885
US-20100286348-A1 HYDROXYARYL FUNCTIONALIZED POLYMERS HAAO, HCAR3, VCL TSHR 3633/4885QDPR 2692/4885PTPN1 1077/4885
US-11117987-B2 Hydroxyaryl functionalized polymers HAAO, HCAR3, VCL TSHR 3633/4885QDPR 2692/4885PTPN1 1077/4885
US-20190233557-A1 Hydroxyaryl Functionalized Polymers HAAO, HCAR3, VCL TSHR 3597/4885QDPR 2846/4885PTPN1 1207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.